| Active Not Recruiting | GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Patients With Locally Advanced Rectal Cancer | — | 2023-05-26 |
| Recruiting | Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS) Squamous Cell Carcinoma of the Anal Canal | Phase 2 | 2023-02-14 |
| Unknown | Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). Metastatic Colorectal Cancer | Phase 2 | 2022-07-07 |
| Active Not Recruiting | Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer | Phase 2 | 2021-06-29 |
| Unknown | Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer Rectal Cancer | Phase 2 | 2019-12-18 |
| Unknown | Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal Colorectal Cancer Metastatic | Phase 2 | 2018-11-08 |
| Completed | Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients Colorectal Carcinoma | Phase 1 / Phase 2 | 2018-03-12 |
| Completed | FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma, Colorectal Cancer Metastatic | Phase 2 | 2017-10-31 |
| Completed | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surger Rectal Cancer | Phase 2 | 2017-05-30 |
| Completed | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal C Rectal Cancer | Phase 2 | 2015-01-01 |
| Unknown | Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer Metastatic Colon Cancer | — | 2014-08-01 |
| Completed | Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Seconda Colorectal Cancer, Hepatic Metastasis | Phase 4 | 2011-11-16 |
| Completed | Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer Pancreatic Adenocarcinoma | Phase 2 | 2011-05-01 |
| Completed | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cet Colorectal Cancer | Phase 2 | 2011-01-01 |
| Completed | Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2010-11-08 |
| Completed | Vectibix for the Treatment of Anal Cancer Anal Squamous Cell Carcinoma | Phase 2 | 2010-10-01 |
| Unknown | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Metastatic Colorectal Cancer | Phase 2 | 2009-11-01 |
| Completed | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum Rectum Cancer | Phase 2 | 2009-03-01 |
| Completed | Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatm Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) | Phase 2 | 2008-10-01 |
| Completed | Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Ca Pancreatic Cancer | Phase 1 | 2007-12-01 |